68ga-fapi
Small moleculeexperimentalImaging agent
Clinical trial activity
26 trials · 13 clinical orgs · 0 marketing orgs
Phase 1
18
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Jul 15, 2019 (NCT04023240)
Timeline
Indications
Studied for
- Acquired Hyperostosis Syndrome · Early Phase 1
- Arthritis · Early Phase 1
- Arthritis, Psoriatic · Early Phase 1
- Atherosclerosis · Early Phase 1
- Heart Failure, Diastolic · Phase 2
- Immunoglobulin G4-Related Disease · Early Phase 1
- Inflammatory Bowel Diseases · Early Phase 1
- Keloid · Phase 1
- Lung Neoplasms · Early Phase 1
- Myositis · Early Phase 1
- Neoplasms · Phase 2
- Non-alcoholic Fatty Liver Disease · Phase 2
- Pulmonary Fibrosis · Phase 1
- Sjogren's Syndrome · Phase 1/Phase 2
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 68-gallium
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07313033 | N/A | Mar 30, 2026 | University of Lyon |
| NCT07083011 | Phase 2 | Nov 30, 2025 | Mayo Clinic |
| NCT06160271 | Phase 2 | Sep 1, 2024 | University of Lorraine |
| NCT06688305 | Early Phase 1 (Phase 1) | Aug 1, 2024 | Fujian Medical University |
| NCT07062523 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2024 | Chinese Academy of Medical Sciences |
| NCT06455761 | Early Phase 1 (Phase 1) | Apr 1, 2024 | Fujian Medical University |
| NCT06740240 | Early Phase 1 (Phase 1) | Mar 1, 2024 | Fujian Medical University |
| NCT06455735 | Early Phase 1 (Phase 1) | Mar 1, 2024 | Fujian Medical University |
| NCT05930457 | Phase 1 | Jul 26, 2023 | Guangzhou Medical University, Sinotau Pharmaceutical Group |
| NCT06684028 | N/A | Jul 12, 2023 | Jiangnan University |
| NCT05952531 | Early Phase 1 (Phase 1) | Jul 1, 2023 | Xiamen University |
| NCT05814835 | Phase 1 | Dec 7, 2022 | People's Liberation Army of China, Sinotau Pharmaceutical Group |
| NCT05691894 | Early Phase 1 (Phase 1) | Nov 2, 2022 | Jiangnan University |
| NCT05686876 | Early Phase 1 (Phase 1) | Nov 1, 2022 | Chinese Academy of Medical Sciences |
| NCT05543954 | Early Phase 1 (Phase 1) | Sep 3, 2022 | Chinese Academy of Medical Sciences |
| NCT06270394 | N/A | Apr 28, 2022 | Anhui Medical University, National Natural Science Foundation of China |
| NCT05275699 | Phase 1 | Mar 1, 2022 | Chinese Academy of Medical Sciences |
| NCT05121779 | Phase 1 | Dec 1, 2021 | Chinese Academy of Medical Sciences |
| NCT05499936 | N/A | Oct 1, 2021 | Chinese Academy of Medical Sciences |
| NCT05036759 | Early Phase 1 (Phase 1) | May 26, 2021 | Chinese Academy of Medical Sciences |
Showing 20 of 26 trials
Page 1 / 2
Organizations
Research & Development (13)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chinese Academy of Medical Sciences | Academic/Hospital | 11 | 11 | 3 | 2019 |
| Fujian Medical University | Academic/Hospital | 4 | 4 | 1 | 2024 |
| Jiangnan University | Academic/Hospital | 2 | 2 | 2 | 2022 |
| Sinotau Pharmaceutical Group | Academic/Hospital | 2 | 0 | 1 | 2022 |
| Xiamen University | Academic/Hospital | 2 | 2 | 2 | 2021 |
| Anhui Medical University | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Guangzhou Medical University | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Mayo Clinic | Academic/Hospital | 1 | 1 | 1 | 2025 |
| National Natural Science Foundation of China | Government | 1 | 0 | 1 | 2022 |
| People's Liberation Army of China | Government | 1 | 1 | 1 | 2022 |
| Stanford University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| University of Lorraine | Academic/Hospital | 1 | 1 | 1 | 2024 |
| University of Lyon | Academic/Hospital | 1 | 1 | 1 | 2026 |
13 organizations
Page 1 / 1